menu search

CNTG / CENTOGENE to Participate in Upcoming Conferences in November

CENTOGENE to Participate in Upcoming Conferences in November
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced itsĀ conference schedule for November 2022. The Company's Pharma and CRO business development team and Diagnostics sales team will be attending events in the U.S. and Spain. CENTOGENE invites attendees to schedule one-on-one meetings. Read More
Posted: Nov 10 2022, 06:30
Author Name: GlobeNewsWire
Views: 092189

CNTG News  

Centogene shares climb after study confirms biomarker for Gaucher disease

By Market Watch
September 1, 2023

Centogene shares climb after study confirms biomarker for Gaucher disease

Shares of Centogene NV CNTG, +8.31% gained 7% premarket on Friday after the company announced data confirming the utility of its proprietary biomarker more_horizontal

CENTOGENE to Participate in Upcoming Conferences in May

By GlobeNewsWire
May 5, 2023

CENTOGENE to Participate in Upcoming Conferences in May

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 05, 2023 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner f more_horizontal

CENTOGENE to Participate in Upcoming Conferences in December

By GlobeNewsWire
December 1, 2022

CENTOGENE to Participate in Upcoming Conferences in December

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner more_horizontal

CENTOGENE to Participate in Upcoming Conferences in November

By GlobeNewsWire
November 10, 2022

CENTOGENE to Participate in Upcoming Conferences in November

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner more_horizontal

Centogene N.V. (CNTG) CEO Kim Stratton on Q4 2021 Results - Earnings Call Transcript

By Seeking Alpha
March 30, 2022

Centogene N.V. (CNTG) CEO Kim Stratton on Q4 2021 Results - Earnings Call Transcript

Centogene N.V. (CNTG) CEO Kim Stratton on Q4 2021 Results - Earnings Call Transcript more_horizontal

Centogene, Twist Join Forces For Custom Test Kits For Rare Diseases

By Benzinga
October 6, 2021

Centogene, Twist Join Forces For Custom Test Kits For Rare Diseases

Centogene NV (NASDAQ: CNTG) and Twist Bioscience Corporation (NASDAQ: TWST) have signed a contract to develop and commercialize custom assay kits for more_horizontal

Centogene, Twist Join Forces For Custom Test Kits For Rare Diseases

By Benzinga
October 6, 2021

Centogene, Twist Join Forces For Custom Test Kits For Rare Diseases

Centogene NV (NASDAQ: CNTG) and Twist Bioscience Corporation (NASDAQ: TWST) have signed a contract to develop and commercialize custom assay kits for more_horizontal

Centogene, Twist Join Forces For Custom Test Kits For Rare Diseases

By Benzinga
October 6, 2021

Centogene, Twist Join Forces For Custom Test Kits For Rare Diseases

Centogene NV (NASDAQ: CNTG) and Twist Bioscience Corporation (NASDAQ: TWST) have signed a contract to develop and commercialize custom assay kits for more_horizontal


Search within

Pages Search Results: